1. Home
  2. PEBO vs CAPR Comparison

PEBO vs CAPR Comparison

Compare PEBO & CAPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Peoples Bancorp Inc.

PEBO

Peoples Bancorp Inc.

N/A

Current Price

$31.90

Market Cap

1.2B

Sector

Finance

ML Signal

N/A

Logo Capricor Therapeutics Inc.

CAPR

Capricor Therapeutics Inc.

N/A

Current Price

$33.23

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PEBO
CAPR
Founded
1902
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.3B
IPO Year
2005
2011

Fundamental Metrics

Financial Performance
Metric
PEBO
CAPR
Price
$31.90
$33.23
Analyst Decision
Buy
Strong Buy
Analyst Count
5
8
Target Price
$33.50
$41.38
AVG Volume (30 Days)
212.1K
921.3K
Earning Date
04-22-2026
01-01-0001
Dividend Yield
5.13%
N/A
EPS Growth
N/A
N/A
EPS
2.99
N/A
Revenue
$197,000.00
$22,270,465.00
Revenue This Year
$17.29
N/A
Revenue Next Year
$2.97
$17,308.50
P/E Ratio
$10.70
N/A
Revenue Growth
N/A
N/A
52 Week Low
$26.21
$4.30
52 Week High
$34.33
$40.37

Technical Indicators

Market Signals
Indicator
PEBO
CAPR
Relative Strength Index (RSI) 42.75 72.22
Support Level $29.27 $22.09
Resistance Level $32.02 $40.37
Average True Range (ATR) 0.85 1.84
MACD -0.22 0.47
Stochastic Oscillator 28.00 72.33

Price Performance

Historical Comparison
PEBO
CAPR

About PEBO Peoples Bancorp Inc.

Peoples Bancorp Inc (Marietta OH) is a financial holding company. As a community bank, it offers a complete line of banking, insurance, investment, and trust solutions through its financial subsidiaries. It offers demand deposit accounts, savings accounts, real estate mortgage loans, merchant credit card transaction processing services, corporate and personal trust services, life, health, property, and casualty insurance products, and brokerage services. The bank also offers telephone and internet-based banking through both personal computers and mobile devices.

About CAPR Capricor Therapeutics Inc.

Capricor Therapeutics Inc is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with high unmet medical needs. The company's product pipeline includes CAP-1002, deramiocel an allogeneic cardiac-derived cell therapy. Deramiocel is currently advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy. Through its proprietary StealthXTM platform, the group uses its exosome technology to conduct preclinical research focused on vaccinology, delivering oligonucleotides, proteins, and small molecules to treat.

Share on Social Networks: